Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-glucose Co-transporter-2 Inhibitors”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Post-approval studies (Phase 4)UnknownNCT03573102
What this trial is testing

Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients

Who this might be right for
Diabetic Nephropathies
Nahla H Tohami 60
Not applicableStudy completedNCT02792400
What this trial is testing

The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 Inhibitors

Who this might be right for
Type 2 Diabetes
University Hospital, Gentofte, Copenhagen 24
Post-approval studies (Phase 4)WithdrawnNCT04531397
What this trial is testing

Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease

Who this might be right for
ProteinuriaChronic Kidney Diseases
Children's Hospital of Fudan University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06072326
What this trial is testing

DApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation

Who this might be right for
Type 1 Diabetes Mellitus With Diabetic Nephropathy
University Medical Center Groningen 36
Not applicableStudy completedNCT02636192
What this trial is testing

Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic Agents

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 200,000
Post-approval studies (Phase 4)Study completedNCT05735197
What this trial is testing

Effect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease Patients

Who this might be right for
Chronic Kidney DiseasesBone Diseases, Metabolic
Mansoura University 100
Testing effectiveness (Phase 2)UnknownNCT05914857
What this trial is testing

Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients

Who this might be right for
Prediabetic StateImpaired Fasting GlucoseImpaired Glucose Tolerance
Yangjin 120
Not applicableStudy completedNCT03694470
What this trial is testing

Characteristics of Patients With Type 2 Diabetes Mellitus (CVD-RNDR)

Who this might be right for
Type 2 Diabetes
AstraZeneca 10,000
Testing effectiveness (Phase 2)WithdrawnNCT04640493
What this trial is testing

SGLT2-Inhibitors for Sleep Apnea in Heart Failure

Who this might be right for
Heart FailureSleep Disordered Breathing
Columbia University
Not applicableStudy completedNCT06453577
What this trial is testing

Pharmacokinetics of Bisoprolol and SGLT2i in Acutely Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart Failure
Universität des Saarlandes 33
Post-approval studies (Phase 4)Looking for participantsNCT07405216
What this trial is testing

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease (Mild to Moderate)AlbuminuriaAdolescent+1 more
Centenario Hospital Miguel Hidalgo 200
Post-approval studies (Phase 4)Study completedNCT05278962
What this trial is testing

HF Patients With LVADs Being Treated With SGLT2i

Who this might be right for
Heart Failure With Reduced Ejection Fraction
University of Chicago 32
Post-approval studies (Phase 4)Study completedNCT03959501
What this trial is testing

Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy

Who this might be right for
Type 2 DiabetesKetonemia
The University of Hong Kong 60
Not applicableLooking for participantsNCT06398977
What this trial is testing

Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients

Who this might be right for
Peritoneal Dialysis ComplicationRenal Function AggravatedSodium-glucose Co-transporter-2 Inhibitors
Sichuan Academy of Medical Sciences 70
Not applicableStudy completedNCT06000722
What this trial is testing

SGLT-i Use in Diabetic Foot Ulcer Disease

Who this might be right for
Diabetic Foot Ulcer
University of Leicester 21
Very early researchLooking for participantsNCT06430684
What this trial is testing

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

Who this might be right for
Chronic Kidney DiseasesPediatric Kidney Disease
Ann & Robert H Lurie Children's Hospital of Chicago 40
Large-scale testing (Phase 3)Looking for participantsNCT05715814
What this trial is testing

MeChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis

Who this might be right for
Peritoneal Dialysis ComplicationEnd Stage Kidney DiseaseSodium-glucose Co-transporter-2 Inhibitors+2 more
University Health Network, Toronto 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07682350
What this trial is testing

SGLT2i Effect on PTDM Development and Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients: A Randomized, Doubleblind, Placebo Controlled, National Multicenter Trial

Who this might be right for
Kidney Transplant RecipientSodium Glucose Co-Transporter 2 InhibitorsNon-Diabetic Patients+3 more
Odense University Hospital 184
Early research (Phase 1)Study completedNCT07367555
What this trial is testing

Effect Of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors on Body Mass Index After 3 Months of Use in Diabetic Patients

Who this might be right for
Diabete Mellitus
Ariba Shafiq 360
Testing effectiveness (Phase 2)UnknownNCT06113900
What this trial is testing

Assessment of Safety and Efficacy of SGLT2is Among LN Patients

Who this might be right for
Lupus Nephritis
Ain Shams University 50
Next Page